Guardant Health
GH
#1449
Rank
โ‚น1.475 T
Marketcap
โ‚น11,130
Share price
17.09%
Change (1 day)
225.31%
Change (1 year)
Guardant Health is an American company developing blood tests for early detection in high-risk populations and recurrence monitoring in cancer survivors.

EPS for Guardant Health (GH)

EPS in 2026 (TTM): -โ‚น303.54

According to Guardant Health 's latest financial reports the company's current EPS (TTM) is -โ‚น328.19. In 2025 the company made an earnings per share (EPS) of -โ‚น320.44 an increase over its 2024 EPS that were of -โ‚น344.64.

EPS history for Guardant Health from 2018 to 2026

Annual EPS

Year EPS Change
2026 (TTM)-โ‚น303.54-5.27%
2025-โ‚น320.44-7.02%
2024-โ‚น344.64-16.82%
2023-โ‚น414.35-33.12%
2022-โ‚น619.5860%
2021-โ‚น387.2455.04%
2020-โ‚น249.77207.14%
2019-โ‚น81.32-19.81%
2018-โ‚น101.40

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Neogen
NEOG
-โ‚น271.71-17.21%๐Ÿ‡บ๐Ÿ‡ธ USA
Natera
NTRA
-โ‚น240.09-26.84%๐Ÿ‡บ๐Ÿ‡ธ USA